Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $62.8 million.

  • Exagen's Liabilities and Shareholders Equity rose 4407.29% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.6 million, marking a year-over-year increase of 294.12%. This contributed to the annual value of $44.7 million for FY2024, which is 2152.11% down from last year.
  • Per Exagen's latest filing, its Liabilities and Shareholders Equity stood at $62.8 million for Q3 2025, which was up 4407.29% from $58.8 million recorded in Q2 2025.
  • In the past 5 years, Exagen's Liabilities and Shareholders Equity registered a high of $137.5 million during Q1 2021, and its lowest value of $40.3 million during Q1 2025.
  • For the 5-year period, Exagen's Liabilities and Shareholders Equity averaged around $81.6 million, with its median value being $64.2 million (2023).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 6559.19% in 2021, then tumbled by 4002.97% in 2023.
  • Quarter analysis of 5 years shows Exagen's Liabilities and Shareholders Equity stood at $123.4 million in 2021, then plummeted by 30.15% to $86.2 million in 2022, then tumbled by 33.96% to $56.9 million in 2023, then fell by 21.52% to $44.7 million in 2024, then skyrocketed by 40.58% to $62.8 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $62.8 million for Q3 2025, versus $58.8 million for Q2 2025 and $40.3 million for Q1 2025.